Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study.
Butta NV, Arias-Salgado EG, Monzón Manzano E, Acuña P, Álvarez Román MT, Buño-Soto A, Ramos Ramos JC, Belda-Iniesta C, Frías J, Carcas AJ, de Soto LM, de Miguel Buckley R, Lora D, García-Morales MT, Borobia AM, Arribas JR, Jiménez Yuste V; CombiVacS Study Group. Butta NV, et al. Among authors: lora d. Res Pract Thromb Haemost. 2023 Jan;7(1):100049. doi: 10.1016/j.rpth.2023.100049. Epub 2023 Jan 14. Res Pract Thromb Haemost. 2023. PMID: 36685004 Free PMC article.
Validation of a prognostic score for early mortality in severe head injury cases.
Gómez PA, de-la-Cruz J, Lora D, Jiménez-Roldán L, Rodríguez-Boto G, Sarabia R, Sahuquillo J, Lastra R, Morera J, Lazo E, Dominguez J, Ibañez J, Brell M, de-la-Lama A, Lobato RD, Lagares A. Gómez PA, et al. Among authors: lora d. J Neurosurg. 2014 Dec;121(6):1314-22. doi: 10.3171/2014.7.JNS131874. Epub 2014 Sep 19. J Neurosurg. 2014. PMID: 25237737
Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
Pérez-Regadera J, Sánchez-Muñoz A, De-la-Cruz J, Ballestín C, Lora D, García-Martín R, Sotoca A, Pérez-Ruiz E, Lanzós E. Pérez-Regadera J, et al. Among authors: lora d. Am J Clin Oncol. 2011 Aug;34(4):395-400. doi: 10.1097/COC.0b013e3181e84634. Am J Clin Oncol. 2011. PMID: 20859196
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, Alonso-Curbelo D, Suarez J, Osterloh L, Graña O, Mulero F, Megías D, Cañamero M, Martínez-Torrecuadrada JL, Mondal C, Di Martino J, Lora D, Martinez-Corral I, Bravo-Cordero JJ, Muñoz J, Puig S, Ortiz-Romero P, Rodriguez-Peralto JL, Ortega S, Soengas MS. Olmeda D, et al. Among authors: lora d. Nature. 2017 Jun 28;546(7660):676-680. doi: 10.1038/nature22977. Nature. 2017. PMID: 28658220 Free PMC article.
Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.
Prieto LM, González-Tomé MI, Muñoz E, Fernández-Ibieta M, Soto B, Álvarez A, Navarro ML, Roa MÁ, Beceiro J, de José MI, Olabarrieta I, Lora D, Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs. Prieto LM, et al. Among authors: lora d. BMC Infect Dis. 2014 Dec 24;14:700. doi: 10.1186/s12879-014-0700-3. BMC Infect Dis. 2014. PMID: 25808698 Free PMC article.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Among authors: lora d. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.
García-Pérez J, González-Pérez M, Castillo de la Osa M, Borobia AM, Castaño L, Bertrán MJ, Campins M, Portolés A, Lora D, Bermejo M, Conde P, Hernández-Gutierrez L, Carcas A, Arana-Arri E, Tortajada M, Fuentes I, Ascaso A, García-Morales MT, Erick de la Torre-Tarazona H, Arribas JR, Imaz-Ayo N, Mellado-Pau E, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Ochando J, Belda-Iniesta C, Frías J, Alcamí J, Pérez-Olmeda M; CombiVacS study Group. García-Pérez J, et al. Among authors: lora d. EClinicalMedicine. 2022 Jul 1;50:101529. doi: 10.1016/j.eclinm.2022.101529. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35795713 Free PMC article.
Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events.
Martínez-Flores JA, Serrano M, Pérez D, Cámara A G, Lora D, Morillas L, Ayala R, Paz-Artal E, Morales JM, Serrano A. Martínez-Flores JA, et al. Among authors: lora d. J Atheroscler Thromb. 2016 Oct 1;23(10):1242-1253. doi: 10.5551/jat.34488. Epub 2016 Apr 11. J Atheroscler Thromb. 2016. PMID: 27063992 Free PMC article.
89 results